Key result
Balloon-expandable valve-in-valve THV successfully treats degenerated bioBentall graft and aortic tube dissection without complications.
Why the study?
Degeneration of both the valvular prosthesis and aortic conduit after Bentall procedure can occur, and treatment options for combined valve dysfunction and conduit damage are limited when redo surgery is unfeasible.
Does a valve-in-valve procedure with a balloon expandable transcatheter heart valve safely treat combined valve prosthesis dysfunction and aortic tube dissection in a patient with a degenerated biological Bentall graft?
Case Report (n=1)
Does a valve-in-valve procedure with a balloon expandable transcatheter heart valve safely treat combined valve prosthesis dysfunction and aortic tube dissection in a patient with a degenerated biological Bentall graft?
A valve-in-valve procedure can serve as a reliable bail-out strategy for combined aortic valve dysfunction and tube dissection in patients with degenerated Bentall grafts when redo surgery is unfeasible.
No takes yet. Share an insight, caveat, or question.
Supports feasibility of valve-in-valve for degenerated bioBentall with dissection; hypothesis-generating and should not yet change practice.
Fineschi et al. (2022) conducted a case report in Degenerated bioBentall graft with failing stentless bioprosthesis and dissection of the aortic conduit (n=1). Valve-in-valve (ViV) procedure with a balloon expandable transcatheter heart valve was evaluated on Procedure-related complications and sealing of the graft wall false lumen. A valve-in-valve procedure with a balloon expandable transcatheter heart valve successfully treated a degenerated bioBentall graft and aortic tube dissection without procedure-related complications.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: